Terug
Ook genoteerd als
HLNCF
OTC
Dagbereik
€ 9,65
€ 9,77
52-Weeksbereik
€ 8,71
€ 11,42
Volume
14.484.580
50D / 200D Gem.
€ 10,51
/
€ 9,91
Vorige Slotkoers
€ 9,93
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 26,5 | 0,3 |
| P/B | 2,6 | 2,9 |
| ROE % | 10,0 | 3,7 |
| Net Margin % | 15,1 | 3,8 |
| Rev Growth 5Y % | 3,1 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Hold
€ 10,20
+5.2%
Forward K/W
24,1
Forward WPA
€ 0,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
11 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,56
€ 0,55 – € 0,57
|
13 B | 2 |
| FY2029 |
€ 0,55
€ 0,54 – € 0,56
|
13 B | 4 |
| FY2028 |
€ 0,50
€ 0,45 – € 0,54
|
12 B | 6 |
Belangrijkste Punten
Revenue grew 3,11% annually over 5 years — modest growth
ROE of 10,01% — decent returns on equity
Net margin of 15,11% shows strong profitability
Generating 1,97B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,07%
Cash machine — converts 120,88% of earnings into free cash flow
Groei
Revenue Growth (5Y)
3,11%
Revenue (1Y)-3,96%
Earnings (1Y)13,07%
FCF Growth (3Y)5,70%
Kwaliteit
Return on Equity
10,01%
ROIC7,27%
Net Margin15,11%
Op. Margin22,44%
Veiligheid
Debt / Equity
0,52
Current Ratio0,92
Interest Coverage7,28
Waardering
P/E Ratio
26,49
P/B Ratio2,63
EV/EBITDA20,85
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3,96% | Revenue Growth (3Y) | -2,30% |
| Earnings Growth (1Y) | 13,07% | Earnings Growth (3Y) | 24,67% |
| Revenue Growth (5Y) | 3,11% | Earnings Growth (5Y) | 4,07% |
| Profitability | |||
| Revenue (TTM) | 10,79B | Net Income (TTM) | 1,63B |
| ROE | 10,01% | ROA | 5,01% |
| Gross Margin | 64,77% | Operating Margin | 22,44% |
| Net Margin | 15,11% | Free Cash Flow (TTM) | 1,97B |
| ROIC | 7,27% | FCF Growth (3Y) | 5,70% |
| Safety | |||
| Debt / Equity | 0,52 | Current Ratio | 0,92 |
| Interest Coverage | 7,28 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 26,49 | P/B Ratio | 2,63 |
| P/S Ratio | 4,00 | PEG Ratio | 1,65 |
| EV/EBITDA | 20,85 | Dividend Yield | 0,02% |
| Market Cap | 43,19B | Enterprise Value | 50,46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10,79B | 11,23B | 11,30B | 10,86B | 9,55B |
| Net Income | 1,63B | 1,44B | 1,05B | 1,06B | 1,39B |
| EPS (Diluted) | 0,36 | 0,32 | 0,24 | 0,24 | 0,30 |
| Gross Profit | 6,99B | 6,95B | 6,96B | 6,58B | 5,95B |
| Operating Income | 2,42B | 2,21B | 2,00B | 1,83B | 1,64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32,57B | 34,32B | 34,06B | 34,82B | 34,45B |
| Total Liabilities | 16,12B | 18,09B | 17,33B | 18,36B | 7,97B |
| Shareholders' Equity | 16,40B | 16,17B | 16,61B | 16,33B | 26,36B |
| Total Debt | 8,59B | 10,10B | 9,46B | 10,44B | 991,00M |
| Cash & Equivalents | 1,32B | 2,20B | 1,04B | 684,00M | 414,00M |
| Current Assets | 4,54B | 5,72B | 4,82B | 4,06B | 5,25B |
| Current Liabilities | 4,92B | 5,81B | 4,64B | 4,37B | 4,24B |